InsiderClue
Insiders · Profile

MACKENZIE ALEXANDER R

Executive Vice President at Pfizer. Filing since 7 Aug 2017. CIK 0001678459

Company
Date
Role
Action
Shares
Amount
Of holding
PFE Pfizer
2 Dec 2021
Executive Vice President
Sold, plan not stated
41,360
$2.24M
32.2%
PFE Pfizer
20 Jun 2019
Executive Vice President
Sold, plan not stated
30,000
$1.32M
27.2%
PFE Pfizer
1 Apr 2019
Executive Vice President
Sold, plan not stated
15,000
$642.50K
12.0%
PFE Pfizer
3 Aug 2018
Executive Vice President
Sold, plan not stated
25,642
$1.01M
20.0%
PFE Pfizer
15 Dec 2017
Executive Vice President
Sold, plan not stated
6,750
$249.75K
6.1%
PFE Pfizer
1 Nov 2017
Executive Vice President
Sold, plan not stated
7,350
$256.81K
6.3%
PFE Pfizer
2 Oct 2017
Executive Vice President
Sold, plan not stated
7,350
$262.03K
5.9%
PFE Pfizer
1 Sep 2017
Executive Vice President
Sold, plan not stated
7,350
$249.90K
5.6%
PFE Pfizer
31 Aug 2017
Executive Vice President
Sold, plan not stated
7,350
$249.90K
5.3%
PFE Pfizer
7 Aug 2017
Executive Vice President
Sold, plan not stated
15,000
$502.56K
9.7%
10 decisions on file.